Issue link: https://www.e-digitaleditions.com/i/1475629
This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 30 August 2022 Inhalation SPECIAL SECTION Particle Manufacturing This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. Powder dosing and device assembly technologies 3P innovation is a global leader in powder dispensing technologies and custom filling and sealing automa- tion equipment. Our proprietary gravimetric technol- ogy, Fill2Weight, enables users to dose accurately and quickly to sub-1 mg levels of the most challenging and sensitive powders. Based in the UK, we have a long history of supplying custom automation equipment to enabling filling and sealing of innovative delivery devices for both orally and nasally inhaled powders. Our approach to custom automation de-risks the manufacturing process for our customers, from early stage clinical trials through commercial scale. 3P innovation UK: +44 1926 408933 enquiries@3pinnovation.com www.3pinnovation.com Pre-formulation to commercialization From pre-formulation to commercialization, Catal- ent has the capabilities and expertise to develop and manufacture inhaled drug products for dry powder inhalers (DPIs). Leveraging its development and ana- lytical capabilities in RTP/Morrisville, North Caro- lina, combined with clinical- and commercial-scale spray drying, powder encapsulation and blister pack- aging capabilities in Boston, Massachusetts, Catalent offers end-to-end support to help progress customers' molecules from development through product launch and beyond. Catalent US: + 1 888 SOLUTION (765-8846) www.catalent.com Fully integrated solutions for dry powder inhalation Hovione is a fully integrated solution provider for dry powder inhalation (DPI). With extensive expe- rience in spray drying, jet milling and other particle engineering technologies, as well as precision capsule filling, Hovione is equipped to address challenges for small molecules and biologics. Hovione's science- based methodology, highly specialized devices, and state-of-the-art equipment for traditional and advanced platforms, enable the formulation of DPIs from low to high dosage with a streamlined approach from screening to commercial. Hovione Portugal: +351 21 982 9000 www.hovione.com